Not Rated
|
Fund Size
(0.09% of Investment in Category)
|
Expense Ratio
(0.88% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 10-Nov-25 | 10030.10 | 0.30% | - | 1.33% | 218/231 |
| 1 Month | 17-Oct-25 | 10083.90 | 0.84% | - | 1.22% | 135/228 |
| 3 Month | 14-Aug-25 | 10186.80 | 1.87% | - | 5.29% | 202/224 |
| 6 Month | 16-May-25 | 11193.40 | 11.93% | - | 7.04% | 20/214 |
| YTD | 01-Jan-25 | 10472.60 | 4.73% | - | 6.08% | 102/200 |
| 1 Year | 14-Nov-24 | 11342.30 | 13.42% | 13.31% | 9.18% | 47/187 |
| Since Inception | 06-Feb-24 | 14669.00 | 46.69% | 24.01% | 14.64% | 17/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 14-Nov-24 | 12000 | 13061.99 | 8.85 % | 16.68 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 375.2 | 7.82% | 1.01% | 11.31% (Apr 2025) | 6.09% (Aug 2025) | 2.22 L | 32.89 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 329.6 | 6.87% | 4.10% | 7.76% (May 2025) | 2.28% (Aug 2025) | 48.92 k | 27.34 k |
| J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 311.3 | 6.48% | -0.46% | 6.94% (Sep 2025) | 0% (Nov 2024) | 1.85 L | 5.43 k |
| Fortis Healthcare Ltd. | Hospital | 303.5 | 6.32% | -0.37% | 6.69% (Sep 2025) | 3.19% (Nov 2024) | 2.97 L | -8.55 k |
| Laurus Labs Ltd. | Pharmaceuticals | 224.6 | 4.68% | 0.40% | 4.68% (Oct 2025) | 2.18% (Jan 2025) | 2.36 L | 10.34 k |
| Cipla Ltd. | Pharmaceuticals | 201.4 | 4.20% | -0.36% | 8.07% (Feb 2025) | 4.2% (Oct 2025) | 1.34 L | 0.00 |
| Neuland Laboratories Ltd. | Pharmaceuticals | 183.6 | 3.82% | 0.62% | 3.82% (Oct 2025) | 1.3% (Feb 2025) | 11.14 k | 1.45 k |
| Lupin Ltd. | Pharmaceuticals | 179.2 | 3.73% | 0.59% | 5.58% (Mar 2025) | 1.15% (Jul 2025) | 91.24 k | 18.56 k |
| Sai Life Sciences Ltd. | Petrochemicals | 141.3 | 2.94% | 0.05% | 2.94% (Oct 2025) | 0% (Nov 2024) | 1.54 L | 5.35 k |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 131 | 2.73% | -1.36% | 4.09% (Sep 2025) | 2.73% (Oct 2025) | 1.82 L | -0.77 L |
Investment / Portfolio Grades
| Security Type |
% Weight |
Category Average |
|---|---|---|
| Government Backed | 3.67% | 0.44% |
| Low Risk | 0.00% | 0.00% |
| Moderate Risk | 0.00% | 0.00% |
| High Risk | 0.00% | 0.00% |
| Very High Risk | 0.00% | 0.00% |
| Others | 0.00% | 0.00% |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 5.50% |
| Net Receivables | Net Receivables | -0.05% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 421.51 | 2.75 | 14.90 | 45.71 | 45.35 | 37.04 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 273.51 | 0.99 | 2.73 | 14.92 | 29.78 | 15.95 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 680.73 | 4.59 | 10.15 | 19.63 | 27.32 | 0.00 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 297.12 | 1.74 | 8.55 | 17.85 | 24.60 | 13.66 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1733.63 | -0.66 | 10.43 | 19.32 | 24.58 | 0.00 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 333.18 | 3.84 | 9.67 | 9.60 | 24.09 | 15.83 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 9273.44 | 3.03 | 7.61 | 12.01 | 23.52 | 21.10 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1518.73 | 1.60 | 8.54 | 8.13 | 23.39 | 0.00 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7556.72 | 0.54 | 6.08 | 5.62 | 23.22 | 0.00 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 292.35 | 2.30 | 3.80 | 13.49 | 23.18 | 17.98 |
Out of 19 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 2 is/are ranked 4 * , and 15 schemes are not ranked. See more about AMC